Race Oncology Ltd. (AU:RAC) has released an update.
Race Oncology Ltd has announced the issue of 4,346,352 new options, exercisable at $1.25 each, with an expiration date set for May 29, 2026. This move, dated May 30, 2024, could potentially dilute existing shares but also suggests a strategic growth plan by the company. Investors in Race Oncology should note this development as it may influence the company’s stock value and future market dynamics.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.
